Skip to main content
Equibles
NHP logo

NHP · National Healthcare Properties, Inc.

Track NHP — free

Use NHP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.14 +0.11 (+0.69%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.17B
Shares
72.90M

NHP metrics

58 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$16.14
Market cap
$1.17B

Price action

19 metrics
Price change (1W)
-3.7%
Price change (30D)
+5.2%
Price change (3M)
+11.2%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
37.4%
Beta
—
RSI (14D)
46.4
Price vs SMA 50
+1.6%
Price vs SMA 200
—
Avg volume (3M)
784,434
Relative volume
0.5
Average dollar volume
$11.99M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
72.90M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.5%
P / book
1.1
reciprocal yield 90.2%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
23.0
reciprocal yield 4.3%
Earnings yield
-3.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
$0.08
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2026-07-15

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
37.9%
Operating margin
3.2%
Trailing 12 months
Net margin
-13.1%
Gross profit (TTM)
$130.42M
Operating profit (TTM)
$10.99M
Net income (TTM)
−$45.00M
Trailing 12 months
Diluted EPS (TTM)
$-1.88
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$0.32
Capital expenditures per diluted share (TTM)
$0.18
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$20.84

Growth

11 metrics
Revenue growth YoY
+2.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$344.32M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+117.7%
Year over year · more shares
Revenue CAGR (3Y)
+0.6%
Revenue CAGR (5Y)
-2.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-24.5%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.3%
Return on assets
-2.3%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
$82.55M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
0.2
Net debt / EBITDA
-3.0
Return on invested capital
—
Trailing 12 months
Net cash
$245.69M
Latest balance sheet
Cash & equivalents
$245.69M
Total assets
$1.98B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$50.75M
Capital expenditures (TTM)
$16.72M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.42M
R&D / revenue
—
Stock compensation / revenue
1.6%

Ownership (13F)

3 metrics
13F filers
93
13F filer change QoQ
+93
Institutional ownership
72.9%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1561032 CUSIP 42226B501 13F (30d) 85 filings 79 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)